All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| anagrelide | CHEBI_142290 | [A 1,5-dihydroimidazo[2,1-]quinazoline having an oxo substituent at the 2-position and chloro substituents at the 6- and 7-positions.] |
| antifibrinolytic drug | CHEBI_48675 | [A drug that prevent fibrinolysis or lysis of a blood clot or thrombus.] |
| platelet aggregation inhibitor | CHEBI_50427 | [A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.] |
| N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-(2-thiazolyl)benzamide | CHEBI_111713 | |
| anidulafungin | CHEBI_55346 | [A semisynthetic echinocandin anti-fungal drug. It is active against Aspergillus and Candida species and is used for the treatment of invasive candidiasis.] |
| echinocandin | CHEBI_57248 | [Any one of a family of large lipopeptides that are inhibitors of the enzyme 1,3-beta-glucan synthase, thus damaging fungal cell walls. Echinocandins are fungicidal against most Candida spp and fungistatic against Aspergillus spp.] |
| semisynthetic derivative | CHEBI_72588 | [Any organic molecular entity derived from a natural product by partial chemical synthesis.] |
| azamacrocycle | CHEBI_52898 | [A cyclic macromolecule containing one or more nitrogen atoms in place of carbon either as the divalent group NH for the group CH2 or a single trivalent nitrogen atom for the group CH.] |
| heterodetic cyclic peptide | CHEBI_24533 | [A heterodetic cyclic peptide is a peptide consisting only of amino-acid residues, but in which the linkages forming the ring are not solely peptide bonds; one or more is an isopeptide, disulfide, ester, or other bond.] |
| antibiotic antifungal drug | CHEBI_87113 | [Any antibiotic antifungal agent used to treat fungal infections in humans or animals.] |
| 4-chloro-N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide | CHEBI_111714 | |
| vitamin K antagonist | CHEBI_55347 | [A class of anticoagulants which act by inhibiting the action of vitamin K.] |
| 4-chloro-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide | CHEBI_111715 | |
| morphine hydrochloride trihydrate | CHEBI_55348 | [The trihydrate of morphine hydrochloride.] |
| morphine hydrochloride | CHEBI_55340 | [The hydrochloride salt of morphine.] |
| antidiarrhoeal drug | CHEBI_55323 | [Any drug found useful in the symptomatic treatment of diarrhoea.] |
| opioid analgesic | CHEBI_35482 | [A narcotic or opioid substance, synthetic or semisynthetic agent producing profound analgesia, drowsiness, and changes in mood.] |
| antitussive | CHEBI_51177 | [An agent that suppresses cough. Antitussives have a central or a peripheral action on the cough reflex, or a combination of both. Compare with expectorants, which are considered to increase the volume of secretions in the respiratory tract, so facilitating their removal by ciliary action and coughing, and mucolytics, which decrease the viscosity of mucus, facilitating its removal by ciliary action and expectoration.] |
| 4-[[[(2S,3S)-10-[[cyclopropyl(oxo)methyl]amino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzoic acid | CHEBI_111716 | |
| benzoic acids | CHEBI_22723 | [Any aromatic carboxylic acid that consists of benzene in which at least a single hydrogen has been substituted by a carboxy group.] |